- Home
- RLAY vs FSM Comparison
RLAY vs FSM Comparison
Compare RLAY & FSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | FSM |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.1B |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | RLAY | FSM |
|---|---|---|
| Price | $18.41 | $9.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $27.58 | $13.75 |
| AVG Volume (30 Days) | 2.4M | ★ 4.7M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $38.41 |
| Revenue Next Year | $60.15 | $21.83 |
| P/E Ratio | ★ N/A | $14.10 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $5.95 | $7.90 |
| 52 Week High | $21.27 | $13.85 |
Technical Indicators
Market Signals| Indicator | RLAY | FSM |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 45.15 |
| Support Level | $17.45 | $8.95 |
| Resistance Level | $20.31 | $10.07 |
| Average True Range (ATR) | 1.15 | 0.39 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 44.29 | 49.03 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'voire, Mexico, and Peru. The company's segment consists of Mansfield, Sango, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d' Ivoire location.